The Association Between Short-Acting β 2 -Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia.

David J PriceChristine JenkinsKerry HancockRebecca VellaFlorian HeraudPorsche Le ChengRuth MurrayMaarten BeekmanSinthia Bosnic-AnticevichFabio BotiniVictoria CarterAngelina CatanzaritiJoe DoanKirsty FlettonAta KichkinThao LeChantal Le LievreChi Ming LauDominique NovicJohn PakosKanchanamala RanasingheAlexander RoussosJosephine Samuel-KingAnita SharmaDeb StewartBruce WilletEric Batemannull null

Published in: Advances in therapy (2024)

Both self-reported SABA overuse and zero SABA prescriptions were associated with poor asthma outcomes. The disconnect between prescribing authorisation, OTC availability and actual use, make it difficult for clinicians to quantify SABA use.

Keyphrases

chronic obstructive pulmonary disease
patient reported
lung function
allergic rhinitis
primary care
cystic fibrosis
electronic health record
palliative care
type diabetes
air pollution
adipose tissue
emergency department
adverse drug
skeletal muscle